Abstract
Hyperthyroidism is associated with unpleasant symptoms and hypertension due to increased adrenergic tone. Therefore, beta-blockers are often used in hyperthyroid patients. While some beta-blockers (such as propronolol and metoprolol) may have unwanted effects on lipid profile, carvedilol, a new alpha- and beta-blocker, has been suggested to have some metabolic advantages with respect to lipid profiles in hypertensive patients. However, this has not been shown in hyperthyroid patients. We aimed to compare the effects of two beta-blockers (metoprolol and carvedilol) on the lipid profiles of hyperthyroid patients with hypertension. Thirty patients with hyperthyroidism and hypertension were randomly assigned to receive either carvedilol (n = 15) or metoprolol (n = 15). Thyroid-stimulating hormone (TSH), free T3, free T4, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride, and total cholesterol levels were measured before and following 3 months of treatment. Systolic and diastolic blood pressure, heart rate, TSH, and free T4 improved significantly in both treatment groups. There were no statistically significant changes in the lipid parameters in either of the two treatment groups...Continue Reading
References
Jan 1, 1991·Journal of Cardiovascular Pharmacology·Y GotoA Yamazaki
Jan 1, 1990·European Journal of Clinical Pharmacology·H SeguchiS Takahashi
Jul 1, 1990·Circulation·L S KleinD P Zipes
Jan 1, 1985·Journal of Cardiovascular Pharmacology·A Lehtonen
Aug 1, 1972·The Journal of Clinical Investigation·E A Nikkilä, M Kekki
Feb 1, 1993·Drugs·D McTavishE M Sorkin
Jan 15, 1995·Annals of Internal Medicine·B L KasiskeT A Louis
Aug 1, 1994·Hypertension·S W RabkinS G Carruthers
Jun 15, 1997·Annals of Internal Medicine·D GiuglianoF D'Onofrio
Jan 5, 2000·American Heart Journal·M R Weir, M Moser
Mar 11, 2000·American Journal of Hypertension·W B Kannel
Jun 8, 2000·The Journal of Clinical Endocrinology and Metabolism·M J DiekmanW M Wiersinga
Nov 10, 2001·The Journal of Clinical Endocrinology and Metabolism·A CachefoM Beylot
Dec 21, 2002·Lancet·Sarah LewingtonUNKNOWN Prospective Studies Collaboration
Aug 21, 2003·Lancet·David S Cooper
Nov 13, 2004·JAMA : the Journal of the American Medical Association·George L BakrisUNKNOWN GEMINI Investigators
Jul 27, 2005·European Journal of Heart Failure·John E SandersonC M Yu
Jul 11, 2006·International Heart Journal·Mehmet UzunluluElif Yorulmaz
Aug 10, 2006·The Journal of Clinical Hypertension·L Michael PrisantAnthony L Mulloy
Oct 5, 2006·Hormones : International Journal of Endocrinology and Metabolism·Evagelos N Liberopoulos, Moses S Elisaf
Nov 28, 2006·Endocrinology and Metabolism Clinics of North America·Bindu Nayak, Kenneth Burman
Jan 9, 2007·Journal of the American College of Cardiology·Faizel OsmanMichael D Gammage
Jun 26, 2007·American Journal of Hypertension·Alan J BankJ Michael Gonzalez-Campoy
Jul 17, 2007·Canadian Journal of Physiology and Pharmacology·Parloop BhattRamesh Goyal
Aug 4, 2007·Endocrinology and Metabolism Clinics of North America·Bindu Nayak, Steven P Hodak
Oct 10, 2007·Circulation·Irwin Klein, Sara Danzi
Mar 28, 2008·The Annals of Pharmacotherapy·Randall P SharpImran M Sharief
Jun 19, 2008·Circulation·Neil ChapmanUNKNOWN ASCOT Investigators
Jun 20, 2008·Diabetes, Obesity & Metabolism·D S H BellJ B McGill
Nov 22, 2008·Ageing Research Reviews·Gus Q Zhang, Weiguo Zhang
Aug 18, 2009·Clinical Endocrinology·P IglesiasJ J Díez